SK pharmteco
Nicholas Duda has over 19 years of work experience in the pharmaceutical and chemical industries. Nicholas started their career as an Undergraduate Research Assistant at Pfizer Pharmaceuticals in 2001. Nicholas then joined Ampac Fine Chemicals in 2003, where they worked as a Chemist, conducting organic synthesis reactions for scale-up and manufacturing. In 2008, they joined GlaxoSmithKline as a Continuous Improvement Project Leader, overseeing API synthesis projects. After that, they returned to Ampac Fine Chemicals in 2011 as a Process Scientist, leading multiple commercial programs and implementing improvement initiatives. In 2013, they were promoted to Director of Business Development at Ampac Fine Chemicals, responsible for developing marketing strategies and capturing business opportunities. Nicholas'smost recent role is the Executive Director of Business Development at SK pharmteco, where they currently serve.
Nicholas Duda attended Brother Rice High School from 1994 to 1998. From 1998 to 2002, they attended Kalamazoo College but did not complete a degree or specify a field of study. In 2000, they briefly studied Language and Grammar Studies at Universidad Nebrija.
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.